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Abstract
Type 1 Diabetes (T1D) is an autoimmune disease where the pancreas produces little to no insulin, which is a hormone that regulates blood glucose
levels. This happens because the immune system attacks (and kills) the beta
cells of the pancreas, which are responsible for insulin production. Higher
levels of glucose in the blood could have very negative, long term effects
such as organ damage and blindness.
To date, T1D does not have a defined cause nor cure, and research
for this disease is slow and difficult due to the invasive nature of T1D
experimentation. Mathematical modeling provides an alternative approach
for treatment development and can greatly advance T1D research. This
thesis describes both a single-compartment and multi-compartment model
for Type 1 Diabetes.
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Chapter 1

Introduction
1.1

Motivation

Diabetes Mellitus, also known as Type 1 Diabetes (T1D), is a condition in
which a person is unable to produce a specific hormone called insulin to
regulate glucose levels in the blood, resulting in high blood glucose levels.
β-cells, which reside in the islet of Langerhans in the pancreas, are
responsible for producing insulin. Insulin’s main purpose is to regulate
glucose in the blood by stimulating cells to absorb the glucose. For people
with T1D, however, the T-cells of the immune system attack and kill off these
β-cells. The cause of the autoimmune attack is currently unknown, but some
potential factors could be a viral infection or environmental factors.
To date, there is no cure for T1D; the only known treatment is insulin
therapy. Management of T1D requires daily injections of insulin, either
through needle injections or an insulin pump. Despite this treatment,
patients with Type 1 Diabetes are at a larger risk for serious health problems,
such as vision loss and heart, kidney, and liver damage.
According to statistics made by the Children’s Hospital in Los Angeles,
about one in 500 people are affected by T1D in the United States. Additionally,
the cost of healthcare for diabetes is approximately 15 billion dollars per
year, and about 80 people are diagnosed with Type 1 Diabetes in the United
States each day. In essence, T1D is affecting millions of people in the United
States and costing billions of dollars each year.
Scientists have been researching various treatments for Type 1 Diabetes,
such as dendritic cell therapy. Dendritic cells (DCs) are thought to reduce or
mitigate the severity of the autoimmune attack on β-cells. More background
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on the effects of dendritic cells are available in Section 1.2.
Shtylla et al. (2019) have developed a single-compartment model that
incorporate β-cell populations, DC populations, macrophage populations,
and T-cells populations. An overview of this model is provided in Chapter 2.
The rest of this thesis uses the single-compartment model as the foundation
for a newly-developed multi-compartment model. Originally, we wanted to
do dynamical systems analysis on the single-compartment model. However,
this model is highly nonlinear, making the analysis very complicated. Thus,
we attempted to simplify the model in a way that would allow a dynamical
systems analysis. However, the preliminary simplified model that we
observed were not adequate in reflecting biological outcomes of real-world
data. Therefore, we went in a different direction and implemented a
multi-compartment model that would better reflect real-world data. The
implementation of this multi-compartment model will more easily allow
for the addition of a treatment compartment. The work on parameter
stochasticity, sampling, and model simplification can be found in Chapter
3. The multi-compartment model can be found in Chapter 4. Chapter 5
contains the discussion and future works for this project.
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1.2

Biological Background

Type 1 Diabetes occurs when the immune system loses self-tolerance to the
autoantigens presented by β-cells in the pancreas (Lo et al. (2018)). This
means that the immune system loses its recognition of the antigens, which
are foreign substances or toxins in the body, that the β-cells present. Because
of this loss in tolerance, parts of the immune system start to attack and kill
the β-cells. Since β-cells are in charge of producing insulin, this results in
a disruption in the production of insulin, resulting in high blood glucose
levels and the eventual development of T1D.
The immune system can be categorized into two parts: an innate response
and an adaptive response. The innate response cells, such as macrophages
and dendritic cells (DC), continuously circulate throughout the body and
consume foreign or dead cells. They also act as messengers and can evoke
an adaptive immune response as necessary, as stated in Gee (2018).
Both macrophages and DCs are antigen-presenting cells (APCs), meaning
that these cells mediate an adaptive immune response by processing and
presenting antigens for recognition by lymphocytes like T-cells. When the
immune system starts to lose tolerance of the antigens presented by β-cells,
the APCs (more prominently, the DCs) present these same antigens on
their surface, evoking the adaptive response. Dendritic cells themselves
can be separated into two categories: tolerogenic and immunogenic. The
tolerogenic DCs signal for a more neutral immune response and encourage
tolerance of the foreign cells. The immunogenic DCs, on the other hand,
provide a signal that evokes a more aggressive immune response attack to
eliminate the targeted cells.
One of the key players of the adaptive immune response are the T-cells.
In this thesis, we will focus on three types of T-cells: effector, memory,
and regulatory T-cells. The effector T-cells are responsible for attacking
any cell that presents the unrecognized antigen, usually signaled by the
immunogenic DCs. The memory T-cells are inactive T-cells that keep track
of the encountered antigens and provide a faster immune response should
the pathogen be presented again. Lastly, the regulatory T-cells, which are
usually summoned by tolerogenic DCs, promote tolerance to foreign cell
antigens by suppressing the effects of effector T-cells.

Chapter 2

Previous Model
2.1

Derivation of Single Compartment Model

This chapter provides an overview of the previously developed singlecompartment model for Type 1 Diabetes and previous simulations of the
model. The following chapters will rely on the foundation work of this
model.
The test subjects in the mathematical models presented in this thesis are
non-obese diabetic (NOD) mice and Balb-c (healthy) mice. The dynamics
of T1D have been thoroughly studied in mice but not in humans, since it is
more difficult and invasive to retrieve data from human test subjects. Since
there are small differences between T1D in mice versus humans, creating
mathematical models for T1D in mice can inform us on the processes and
bodily functions of Type 1 Diabetes in humans.
There are twelve key variables in the single compartment model for Type
1 Diabetes, separated into five categories: macrophages, β-cells, dendritic
cells, the immune system’s T-cells, and glucose/insulin. Their roles are
further described in the following paragraphs.
Table 2.1 shows the 12 variables and their meanings. This table is slightly
modified from the table in the thesis written by M. Gee. We also show the
interactions of these 12 variables in Figure 2.1.
The development of T1D has been linked with lower clearance rates of
macrophages in NOD mice compared to rates in Balb-c mice. Thus, the model
reflects this difference by having lower macrophage clearance rates in sick
mice. In this model, we represent two populations of macrophages: regular
and activated. Activated macrophages differ from regular macrophages in
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Figure 2.1 Here is the diagram of how the twelve different kind of cell populations interact with each other. The green arrows indicate that the cell population
that the arrow is coming from increases or contributes to the population to which
the arrow is pointing. On the other hand, the orange line segment represents
that the cell population that the segment starts from inhibits or decreases the
cell population to which the segment is pointing (the population where the
circle end is).

Derivation of Single Compartment Model 7
Variable name
B
G
I
M
Ma
Ba
Bn
D
tD
E
R
Em

Units
mg
mg dl−1
µU
cells ml−1
cells ml−1
cells ml−1
cells ml−1
cells ml−1
cells ml−1
cells ml−1
cells ml−1
cells ml−1

Meaning
Healthy β-cell population
Glucose levels
Insulin levels
Macrophage population
Active macrophage population
Apoptotic β-cell population
Necrotic β-cell population
Immunogenic DC population
Tolerogenic DC population
Effector T-cell population
Regulatory T-cell population
Memory T-cell population

Initial Value
300 mg
100 mg dl−1
10 µ U
4.77 · 105 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1

Table 2.1 This is the complete list of variables and their initial values involved
in the single-compartment model, which are originally derived in Shtylla et al.
(2019).

that they have engulfed at least a necrotic or apoptotic β-cell. Because of this
engulfment, the activated macrophages are able to present the autoantigens
that apoptotic or necrotic β-cells produce, which notifies the immune system
and potentially triggers an immune response (Maree et al. (2006)).
Additionally, a naturally occurring pre-programmed wave of cell death,
known as the apoptotic wave, has also been found to contribute to the
progression of T1D, as discovered in Trudeau et al. (2000). Figure 2.2 shows
the previously-derived results of β-cell dynamics under four different cases:
NOD mice with the apoptotic wave, NOD mice without the wave, Balb-c
mice with the wave, and Balb-c mice without the wave.
This model separates β-cells into three categories: healthy β-cells, apoptotic β-cells (dying β-cells), and necrotic β-cells (dead β-cells).
We note that T-cells in the immune system are responsible for attacking
and killing the healthy β-cells. Thus, in the model, this cell population
is represented in three categories: effector T-cells, regulatory T-cells, and
memory T-cells. We note that the effector T-cells are the main contributors for
the adaptive immune response mentioned in the previous section, whereas
the regulatory T-cells are responsible for building up a tolerance to foreign
antigens (in this case, the β-cell autoantigens). Lastly, memory T-cells are
inactive T-cells that retain their previous immune response and can quickly
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Figure 2.2 Here are the results of running the simulation on four different
cases: NOD mouse without wave, Balb/c mouse without wave, NOD mouse with
wave, and Balb/c mouse with wave. Only the case of NOD mouse with wave do
we have the development of Type 1 Diabetes, as indicated by the increase in
glucose levels, decrease in the population of β -cells, and the decrease in the
amount of insulin. This figure was previously created in the paper by Shtylla
et al. (2019).

Derivation of Single Compartment Model 9

Figure 2.3 These plots show the behavior of the immune cells (E, R, and Em)
in the presence/absence of a wave in both NOD and Balb-c mice.

transform back to either a regulatory or effector cell to provide a quicker
immune response in the future. The previously-acquired results for the
immune cell population dynamics can be seen in Figure 2.3.
We also track the populations of immunogenic and tolerogenic dendritic
cells, because the DCs are responsible for triggering the adaptive immune
system response. Previously-derived results of dendritic cell dynamics can
be seen in Figure 2.4.
The dynamics of glucose and insulin are a crucial part of creating a
mathematical model for Type 1 Diabetes, as we indicate the distinction
between healthy and diabetic by an increase or spike in blood glucose levels.

10 Previous Model

Figure 2.4 The dynamics of the dendritic cells in the single-compartment
model can be seen here for all four cases.

System of Equations 11

2.2

System of Equations

This section outlines each of the 12 differential equations used to create the
single-compartment model.

Macrophage Populations
d
M  J + (k + b)M a − cM − f M MB a − f M MB n − e1 M(M + M a ) (2.1)
dt
In this equation, we assume that macrophages are flowing in at a constant
rate, J. Additionally, we assume that activated macrophages (M a ) revert
back to regular macrophages (M) at a rate of k. We also know that activated
macrophages recruit macrophages at a rate of b. Thus, the two interactions
with M a results in the (k + b)M a term in the equation. We also see that
macrophages “leave" or “egress" at a rate of c, hence the −cM term. Also
note that when a macrophage consumes an apoptotic or necrotic β-cell, the
macrophage transforms into an activated macrophage. The clearance rate
(AKA engulfment rate) of β-cells for macrophages (M) is f M . Thus, when
necrotic or apoptotic β-cells interact with a macrophage, the population of
macrophages is decreased at a rate of f M , thus explaining the − f M MB a and
− f M MB n terms. Lastly, the term −e1 M(M + M a ) represents the decrease in
population of M due to the crowding effect.

Activated Macrophages Populations
d
M a  f M MB a + f M MB n − kM a − e2 M a (M + M a )
(2.2)
dt
Many of the terms in the M a equation are similar to those of the M equation. As mentioned earlier, we note that macrophages become activated
macrophages at a rate of f M , which is shown by the + f M MB a and + f M MB n
terms in the equation. Also as described before, activated macrophages
revert back to macrophages at a rate of k, which is shown through the −kM a
term. The last term of the equation represents the crowding effect. We note
that, in Equation 2.1, the coefficient in front is e1 whereas in Equation 2.2,
the coefficient is e2 . For this model, e1 and e2 have the same value, since
the crowding effect affects the macrophages and the activated macrophages
equally.
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Healthy β-cell Populations
d
B  α B K 1 (G)B − δ B B − ηK2 (E, R)B − W(B, t)
(2.3)
dt
The first term contains K 1 (G), which is a function relating the population of
healthy β-cells to glucose. In other words, healthy β-cells grow in proportion
to the glucose levels K1 (G) at a rate of α B . In the paper, the function K 1 (G)
is defined as:
G2
K1 (G) 
.
G2 + G 2hb
This function was defined in Graham (2012).
The second term −δ B B indicates that healthy β-cells are dying at a rate
of δ B .
The third term contains a function K 2 (E, R), which is the function that
defines the interaction between T-cells and healthy β-cells. In other words,
the healthy β-cells are dying in proportion to T cells at a rate of η. The
function K 2 , which is originally shown in Moore and Adler (2014), is defined
as follows:
(s E E)2
K2 (E, R) 
1 + (s E E)2 + (s R R)2 .
Lastly, the fourth term represents healthy β-cell death due to the natural
occurrence of an apoptotic wave, as first postulated in Trudeau et al. (2000).
We define W(B, t) as:
t−9 2
W(B, t)  0.1Be −( 9 ) .
This equation implies that the wave peaks at approximately nine days to 10
percent of the healthy β-cell population.

Apoptotic β-cell Populations
d
B a  δ˜B B + η̃K 2 (E, R)B + W̃(B, t) − dB a − f M MB a − f Ma M a B a
dt
− f tD (Dss − D)B a − f D DB a (2.4)
First note that the notation for δ˜B , η̃ and W̃ indicates that we take the original
parameters (δ B , η, W) and multiply it by a constant, QBconv
for unit conversion.
panc
The original units for B is milligrams, whereas the units for B a and B n are
cells/mL.
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The first term represents the conversion of healthy β-cells to apoptotic
β-cells at a rate of δ (with unit conversion). The second term represents
the conversion due to normal apoptosis by T effector cells at a rate of η,
again with unit conversion. The third term represents the conversion of
healthy β-cells to apoptotic cells due to the pre-programmed wave of cell
death. Included also is a death rate d for B a . We also note that macrophages
and activated macrophages are able to clear away the apoptotic β-cells
at rates of f M and f Ma , respectively. In addition, dendritic cells are able
to engulf or clear away necrotic cells. All immature DCs, represented as
Dss − D in the equation, can clear apoptotic β-cells at a rate of f tD , whereas
mature/immunogenic DCs, represented by D, can clear at a rate of f D .

Necrotic β-cell Populations
d
B n  dB a − f M MB n − f Ma M a B n − f tD (Dss − D)B n − f D DB n
(2.5)
dt
We note that B a are converted to necrotic β-cells at a death rate of d. Very similarly to the apoptotic β-cell population, macrophages, activated macrophages,
immature (tolerogenic) dendritic cells, and immunogenic dendritic cells are
able to clear necrotic β-cells at rates of f M , f Ma , f tD , and f D respectively.

Glucose
d
G  R0 − (G0 + SI I)G
(2.6)
dt
For this equation, we assume that glucose enters the bloodstream at a
constant rate of R0 . We also assume that glucose leaves the bloodstream
at a constant rate of G0 . Additionally, glucose is decreased in the presence
of insulin at a rate of SI . This equation and the equation for insulin were
originally derived in Topp et al. (2000).

Insulin
d
G2
I  σI 2
B − δI I
(2.7)
dt
G + GI 2
Insulin is produced at a rate (σI ) proportional to the population of healthy
β-cells in the presence of glucose. Lastly, insulin has a natural decay rate of
δI .
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Immunogenic Dendritic Cell Populations
d
D  f tD B n (Dss − D − tD) + f tD B n tD − b DE ED − µ D D
(2.8)
dt
Dss represents a constant steady state of naive dendritic cells in the pancreas.
When these naive DCs, represented by (Dss − D − tD), engulf necrotic β-cells
at a rate of f tD , they become immunogenic DCs. Tolerogenic DCs can
become activated immunogenic DCs upon engulfing a necrotic cell at a rate
of f tD . Immunogenic DCs are removed by effector T-cells (E) at a rate of b DE
and have a death rate of µ D .

Tolerogenic Dendritic Cell Populations
d
tD  f tD B a (Dss − D − tD) − f tD B n tD − b IR RtD − µ D tD.
(2.9)
dt
When the naive DCs (represented by Dss − D − tD) engulf apoptotic β-cells
at a rate f tD , they become tolerogenic DCs. As mentioned before, tolerogenic
DCs convert to immunogenic DCs upon engulfing a necrotic β-cell at a
rate of f tD , thus explaining the − f tD B n tD term. Regulatory T-cells remove
tolerogenic DCs at a rate of b IR . Also, tolerogenic DCs have a death rate of
µ D , similar to the equation for immunogenic DCs derived in Ludewig et al.
(2004).

Effector T-cell Populations



Tnaive
DE
d
E  aE
− E + bP
− r am E + b E DEm − µE ER
dt
Q sple e n
θD + D

(2.10)

The first term in this equation represents a homeostatic naive T-cell term
that generates effector T-cells. The second term represents the immunogenic
DC-induced proliferation of effector T-cells. This happens at the same rate b P
for both E and R. We note that θD is the DC value for half-maximal effector
T-cell expansion. The r am E term represents the reversion of effector cells to
memory cells at a rate of r am . We note that effector T-cells are reactivated
(from memory T-cells) by immunogenic DCs at a rate of b E , as shown by the
b E DE m term. Lastly, regulatory T-cells supress the actions (“shut down" the
inflammatory response) of the effector T-cells at a rate of µE . Another way to
interpret µE is that this is the rate at which effector T-cells are removed due
to competition between effector and regulatory T-cells, as stated in Ludewig
et al. (2004).

Parameter Values

Regulatory T-cell Populations



Tnaive
tDR
d
R  aR
− R + bP
− r am R + b R tDEm − µ R ER (2.11)
dt
Q sple e n
θD + tD

The regulatory T-cell equation is very similar to the effector T-cell equation.
The first term still represents a homeostatic naive T-cell population that
generates regulatory T-cells at a rate of α R . We note that α R is equal to α E
from the previous equation in this model. Additionally, the second term
represents the tD-induced proliferation of regulatory T-cells at a rate of
b P . Regulatory T-cells convert to memory T-cells at a rate of r am and are
reactivated by tolerogenic DCs at a rate of b R . The last term in this equation
serves the same purpose as the last term of the previous equation. We note
that in our model, µ R  µE .

Memory T-cell Populations
d
Em  r am (E + R) − (a Em + b E D + b R tD)Em
(2.12)
dt
As mentioned above, both effector and regulatory T-cells are reverted to
memory T-cells at a rate of r am . We also mentioned that dendritic cells
reactive the T-cells with rates of b E and b R , which leads to a decrease in the
population of E m . Lastly, memory T-cells have a death rate of a Em .

2.3

Parameter Values

Table 2.2 shows the values of the parameters used in the single-compartment
model. Many of these parameters will also be used in the multi-compartment
model, which is described in Chapter 4.
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Parameter

Balb-c mice

NOD mice

Units

J

5 · 104

5 · 104

cells ml−1 d−1

k

0.4

0.4

d−1

b

0.09

0.09

d−1

c

0.1

0.1

d−1

fM

2 · 0.0623 · 10−5

0.0623 · 10−5

ml cell−1 d−1

e1

10−8

10−8

cell−1 d−1

e2

10−8

10−8

cell−1 d−1

αB
δB

0.0334
1/60

0.0334
1/60

d−1
d−1

η

0.02

0.02

d−1

G hb

90

90

mg dl−1

sE

1

1

ml cells−1

sR

36

36

ml cells−1

B conv

2.59 · 105

2.59 · 105

cell mg−1

Q panc

0.194

0.194

ml

d

0.50

0.50

d−1

f Ma

5 · 0.0623 · 10−5

0.0623 · 10−5

ml cells−1 d−1

f tD

1.1899 · 10−6

1.1899 · 10−6

ml cells−1 d−1

Dss

105

105

cells ml−1

Meaning
normal resting
macrophage influx
Ma deactivation rate
macrophage
recruitment rate by M a
macrophage egress rate
basal phagocytosis rate
per M for Balb-c mice
anti-crowding term for
macrophages
anti-crowding term for
macrophages
β-cell growth rate
β-cell death rate
rate at which T-cells
eliminate β-cells
glucose level of
half-max β-cell
production
Relative impact of
effector T-cells on β-cell
death
Relative impact of
regulatory T-cells on
β-cell death
β-cells per milligram
volume of mouse
pancreas
β-cell death rate
activated phagocytosis
rate per Ma
rate naive DC engulf
apoptotic β-cells
steady-state DC
population

Parameter Values

fD

1.7101 · 10−7

1.7101 · 10−7

ml cells−1 d−1

R0

864

864

mg dl−1

G0

1.44

1.44

d−1

SI

0.72

0.72

ml µU−1 d−1

σI

43.2

43.2

µU ml−1 d−1 mg−1

GI

141.4214

141.4214

mg dl−1

δI

432

432

d−1

b DE

0.487 · 10−5

0.487 · 10−5

ml cells−1 d−1

µD

0.51

0.51

d−1

b IR

0.487 · 10−5

0.487 · 10−5

ml cells−1 d−1

aE

0.1199

0.1199

d−1

Tnaive

370

370

cells

Q sple e n

0.1

0.1

ml

bp

12

12

d−1

θD

2.12 · 105

2.12 · 105

d−1

r am

0.01

0.01

d−1

17

rate naive DC engulf
necrotic β-cells
basal rate glucose
production
rate of glucose decay
insulin rate of glucose
elimination
maximum rate of
insulin production by
β-cells
glucose level of
half-max insulin
production
rate of insulin decay
DC elimination rate by
effector T-cells
DC death rate
DC elimination rate by
regulatory T-cells
rate of initial expansion
of naive T-cells to
effector T-cells
number of naive T-cells
contributing to initial
production of effector
and regulatory T-cells
volume of mouse
spleen
maximum expansion
rate of effector T-cells
due to DCs
DC value for
half-maximal effector
T-cell expansion
reversion rate of T-cells
to memory T-cells
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bE

10−3

10−3

µE

2 · 10−6

2 · 10−6

d−1

aR

0.1199

0.1199

d−1

bR

10−3

10−3

ml d cells−1

µR

2 · 10−6

2 · 10−6

d−1

a Em

0.01

0.01

d−1

ml d

cells−1

activation rate for
effector T-cells from
memory T-cells
effector T-cell removal
rate due to competition
rate of initial expansion
of naive T-cells to
regulatory T-cells
activation rate for
regulatory T-cells from
Em T-cells
regulatory T-cell
removal rate due to
competition
memory T-cell death
rate

Table 2.2 A list of the parameters used in the single-compartment model. This
list was derived from the original paper by Shtylla et al. (2019).

2.4

Remaining Open Questions of the Model

Something worth noting is that, when including a DC treatment in the model,
there seemed to be a window of opportunity for which dosages of treatment
would work and otherwise wouldn’t work. The previously-obtained results
can be seen in Figure 2.5.
One explanation of this has to do with the ratio of regulatory T-cells
to effector T-cells. Regulatory T-cells mitigate the inflammatory response
that the effector T-cells have, thus building up a tolerance to the unknown
antigen presented in the body. The higher the ratio, the smaller the immune
response. Ideally, we want the immune response to be reduced so that
healthy β-cells are not accidentally killed off by the effector T-cells. In Figure
2.6, the graph of R/E seems very similar to the graph of the dosage levels.
This is a strong indicator of why the window of opportunity for dosaging
exists.
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Figure 2.5 This figure shows the effects of various levels of treatment dosage
on glucose levels. If the treatment is injected too early, it is ineffectual (panel A).
If the treatment is injected between (roughly) 70 and 160 days, then both low
and high levels of dosage will work. However, after 160 days, the low dosage no
longer works. This indicates that there exists an optimal time frame in which to
inject treatment to prevent the onset of T1D. This figure was created in Shtylla
et al. (2019).
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Figure 2.6 The shape of the graph for the ratio of regulatory T-cells to effector
T-cells and the graph for dosage levels are very similar. This ratio may be the
cause for the “window of opportunity". This figure is from Shtylla et al. (2019).

Chapter 3

Supplementary Work on the
Single-Compartment Model
3.1

Model Simplification

One of the earliest goals of this thesis was to perform dynamical systems
analysis. However, dynamical systems analysis would be very difficult (if not
impossible) since the current single-compartment model is highly nonlinear.
Thus, before performing any sort of analysis, we wanted to see if we could
simplify the model. Specifically, we wanted to linearize the glucose and
insulin equations. In Makroglou et al. (2006), they had a minimal model
for glucose and insulin. The model that was developed in Makroglou et al.
(2006) is as follows:
dG(t)
 −[b1 + X(t)]G(t) + b1 G b ,
dt
dX(t)
 −b 2 X(t) + b3 [I(t) − I b ],
dt
dI(t)
 b 4 [G(t) − b5 ]+ t − b6 [I(t) − I b ],
dt
where G is glucose, X is “an auxiliary function representing insulin-excitable
tissue glucose uptake activity", and I is insulin. Unfortunately, this equation
did not fit well with the single-compartment model. Thus, instead of
continuing to pursue model simplification, we instead went in a different
direction with the model.
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3.2

Stochasticity

The next goal after an attempt at model simplification was to incorporate
stochasticity into the model. From Li et al. (2010), we were able to see blood
glucose levels in various untreated NOD mice. We wanted to be able to
incorporate stochasticity into the model so that we could replicate the results
in figure 3.1.

Figure 3.1 The blood glucose levels were tracked in untreated NOD mice.

In Figure 3.1, we see various possibilities for the onset of Type 1 Diabetes.
There could be an early onset, delayed onset, fast onset, and slow onset.
We wanted to be able to represent all four kinds of onset in our model.
Thus, we experimented with randomly choosing parameter values within a
healthy range. In the beginning, we chose the two most sensitive variables
to experiment with: f M , which is the clearance rate of macrophages, and µ R ,
which is the removal rate for regulatory T-cells due to competition. Results
of this can be found in Figure 3.2.

3.3

Parameter Sampling

Because some combinations of f M and µ R could drive the simulation to a
healthy state, we wanted to experiment with other parameters relating to
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Figure 3.2 This is a graph of the blood glucose levels vs. time when the f M and
µ R parameters have randomized values within a reasonable range. With some
combinations of f M and µ R values, the simulation goes towards a healthy state,
whereas with other combinations, it tends towards a diabetic state instead.
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Figure 3.3 Varying η and f M .

the innate immune system to see if we could get the various types of onset.
Thus, the next step was to take all of the parameters relating to the immune
system and vary them against each other in pairs. The table of parameters
that we varied can be found in Table 3.1.
For the parameters with a sensitivity value of ±50%, this meant that
during the parameter sensitivity testing, their sensitivities were higher than
50%. Thus, we arbitrarily varied their values by ±50%.
With the single-compartment model, we were able to get the fast spiking,
early spiking, and slow spiking when varying two parameters at a time.
However, we were unable to get the delayed spiking. Figures 3.3, 3.4, and
3.5 show some examples of the combinations that we get.
Unfortunately, we still did not see the delayed spiking that was seen
in the real-world data. Thus, we turned to creating a multi-compartment
model for Type 1 Diabetes with the hopes of better reflecting the real-world
data. The multi-compartment model is covered in depth in the next chapter.
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Figure 3.4

Varying s R and s E against each other.

Figure 3.5 Varying f M and b R .
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parameter
η
sR
sE
f Ma
fM
f tD
fD
µR
bR
µE
bE
bP
aR
aE
b IR
b DE
b

meaning
rate at which T-cells
eliminate β-cells
relative impact of R on
β-cell death
relative impact of E on
β-cell death
rate M a engulf B n and
Ba
rate M engulf B n and
Ba
rate naive DCs engulf
Ba
rate naive DCs engulf
Bn
rate of R removal due to
competition
R activation rate from
Em
rate of E removal due to
competition
E activation rate from
Em
maximal expansion rate
of E due to DCs
rate of initial expression
of naive T-cells into R
rate of initial expression
of naive T-cells into E
rate of elimination of
tDCs by R
rate of elimination of
DCs by E
M recruitment rate by
Ma

value

sensitivity

0.02 days−1

+20.2%

36 ml cells−1

± 50%

1 ml cells−1

± 50%

0.0623 × 10−5 ml cells−1
days−1
0.0623 × 10−5 ml cells−1
days−1
1.19 × 10−6 ml cells−1
days−1
1.71 × 10−7 ml cells−1
days−1

+1.7%
+0.74%
-1.3%
±50%

5 × 10−6 d−1

−0.684%

1 × 10−3 ml d cells−1

±50%

5 × 10−6 d−1

+2.8%

1 × 10−3 ml d cells−1

−45.2%

12 d−1

−23.5%

0.1199 d−1

+1.2%

0.1199 d−1

+1.2%

0.487 × 10−5 ml cells−1
d−1
0.487 × 10−5 ml cells−1
d−1
0.09 d−1

−12.3%
±50%
−0.92%

Table 3.1 Table of sampled parameters and their sensitivity values, derived
from Gee (2018).

Chapter 4

Multi-Compartment Model
4.1

Introduction

As mentioned previously, we want to be able to replicate the real world data
with our mathematical model. With the single-compartment model, we
were able to get early spiking, slow spiking, and fast spiking. However, we
were unable to get the delayed spiking. Thus, we wanted to transform the
single-compartment model into a multi-compartment model. A lot of the
groundwork for this model was done by Professors de Pillis and Shtylla.
However, for this thesis, adjustments were made, and the macrophage and
activated macrophage populations were incorporated.
The multi-compartment model consists of three separate compartments:
the bloodstream, the spleen, and the pancreas. Figure 4.1 shows the model
diagram.
The full diagram can be seen in Figure 4.2. Similar to the diagram in
Figure 2.1 for the single-compartment model, this diagram shows how the
cells in each compartment interact with each other and with cells from other
compartments.

4.2

Variables

We outline the 23 different variables used in this model in Table 4.1, along
with their initial conditions.
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Figure 4.1 This is a diagram of the different kinds of compartments in our
multi-compartment model.

Figure 4.2 Here is the full model diagram showing the interactions between
all of the cells.

Variables 29

Variable name

Units

B

mg

G
I

mg dl−1
µU

M

cells ml−1

Mb

cells ml−1

Ma

cells ml−1

Ba

cells ml−1

Bn

cells ml−1

Dpanc

cells ml−1

Ds

cells ml−1

Dblood

cells ml−1

tDpanc

cells ml−1

tDs

cells ml−1

tDblood

cells ml−1

E panc

cells ml−1

Es

cells ml−1

Meaning
Healthy β-cell
population
Glucose levels
Insulin levels
Macrophage
population in the
pancreas
Macrophage
population in the blood
Activated macrophage
population in the
pancreas
Apoptotic β-cell
population
Necrotic β-cell
population
Immunogenic DC
population in the
pancreas
Immunogenic DC
population in the
spleen
Immunogenic DC
population in the blood
Tolerogenic DC
population in the
pancreas
Tolerogenic DC
population in the
spleen
Tolerogenic DC
population in the blood
Effector T-cells in the
pancreas
Effector T-cells in the
spleen

Initial Value
300 mg
100 mg dl−1
10 µU
0 cells ml−1
4.77 · 105 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1

0 cells ml−1
0 cells ml−1
0 cells ml−1

0 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1
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E blood

cells ml−1

R panc

cells ml−1

Rs

cells ml−1

R blood

cells ml−1

Em panc

cells ml−1

Em s

cells ml−1

Em b

cells ml−1

Effector T-cells in the
blood
Regulatory T-cells in
the pancreas
Regulatory T-cells in
the spleen
Regulatory T-cells in
the blood
Memory T-cells in the
pancreas
Memory T-cells in the
spleen
Memory T-cells in the
blood

0 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1
0 cells ml−1

Table 4.1 A list of the 23 variables used in the multi-compartment model with
their initial conditions.

4.3

Equations

We have three separate compartments: the spleen, the pancreas, and the
blood. The blood compartment is mostly used from transporting cells from
one compartment to the other.
Spleen Compartment
DCs in the Spleen





Q blood
d
Ds 
µ B Db − a D Ds − b DE Ds E s
dt
Q sple e n

(4.1)

This equation represents the behavior of the immunogenic dendritic cells in
the spleen. We note that any µ term will typically represent an emigration
rate unless otherwise stated. In this case, dendritic cells from the bloodstream
(Db ) are coming
into the spleen at a rate of µ B . We also have a conversion

rate

Q blood
Q sple e n

because the volumes of the blood and spleen compartment

are different, and concentration is the usual unit of measure for this model.
Dendritic cells in the spleen are also dying at a rate of a D . Lastly, the b DE Ds E s
term represents the same phenomenon as in the single-compartment model:
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dendritic cells in the spleen are being eliminated by effector T-cells in the
spleen (E s ) at a rate of b DE .





Q blood
d
tDs 
µ B tDb − a I tDs − b IR tDs R s
dt
Q sple e n

(4.2)

This equation represents the behavior of the tolerogenic DCs in the spleen.
Similar to the immunogenic DC equation, tolerogenic DCs in the spleen
(tDb ) are emigrating at a rate of µ B . The same conversion factor from above
applies here as well. The tolerogenic DCs are also dying at a rate of a I . Lastly,
tDb cells are eliminated by regulatory T-cells in the spleen (Ts ) at a rate of
b IR .
T-cells in the Spleen









Q blood
Tnaive
d
µ BSE E b − µSB (Ds )E s + b E Ds Em s + a E
− Es
Es 
dt
Q sple e n
Q sple e n
Ds E s
− µE E s R s − r am E s + b p
(4.3)
θD + Ds
This equation represents the behavior of effector T-cells. Effector T-cells
are exiting the blood and entering the spleen at a rate of µ BSE . We note
that because of the difference
in

 compartment volumes, we have to do a
conversion, indicated by

Q blood
Q sple e n

. We also note that µSB (Ds ) is a gating term

represented by:
µSB (DC)  µ∗SB +

∆µ
1+

DC
θshut

(4.4)

normal
where ∆µ = µSB
− µ∗SB . This term represents the dendritic cells signaling
the activated CTLs (cytotoxic T lymphocytes) to flow from the spleen to
the blood. The flow of these T-cells is restricted, as modeled by the gating
term. Similar to the single-compartment model, memory T-cells are being
reactivated as effector T-cells by immunogenic DCs at a rate of b E , effector
T-cells are being generated at a rate of a E , effector T-cells are being removed
due to competition with the regulatory T-cells at a rate of µE , effector T-cells
are reverting back to memory T-cells at a rate of r am , and effector T-cells are
Es
proliferating due to DCs, which is represented by the b P θDD s+D
term.
s
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Q blood
d
Tnaive
Rs 
µ BSE R b − µSB (tDs )R s + b R tDs Em s + a R
− Rs
dt
Q sple e n
Q sple e n
tDs R s
(4.5)
− µ R E s R s − r am R s + b P
θD + tDs
This equation represents the behavior of the regulatory T-cells in the spleen.
We note that this equation is very similar to the effector T-cells equation - the
slight differences are that tolerogenic DCs (tDs ) interact with the regulatory
T-cells (R) instead of immunogenic DCs (Ds ) with effector T-cells (E), and the
parameters are labeled differently. b R is the rate at which memory T-cells are
being converted to tolerogenic DCs, and a R is the rate at which R is being
generated from naive T-cells.





Q blood
d
µ BSE Em b − µSB (Ds )Em s + r am (E s + R s )
Em s 
dt
Q sple e n
− (a Em + b E Ds + b R tDs )Em s

(4.6)

This equation represents the behavior of memory T-cells in the spleen. We
note that the first two terms are very similar to the E s and R s equations. The
r am (E s + R s ) term represents effector and regulatory T-cells converting to
memory T-cells at a rate of r am . a Em is the death rate, and memory T-cells
are converted back to effector and regulatory T-cells by immunogenic DCs
and tolerogenic DCs at rates of b E and b R , respectively.
Blood Compartment
DCs in the Bloodstream
Q panc
d
Db  −µ B Db +
µPB Dpanc
dt
Q blood





(4.7)

This is the equation for immunogenic dendritic cells in the blood. We note
that µ B is the rate at which DCs are leaving the blood (to enter the spleen
compartment). µPB represents the DC emigration rate from the pancreas to
the blood. Again, we have a conversion factor to account for the difference
in compartment volumes.
Q panc
d
tDb  −µ B tDb +
µPB tDpanc
dt
Q blood





(4.8)
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This is the equation for tolerogenic DCs in the blood. We note that this
equation is almost identical to the immunogenic DCs equation - the only
change is that Db is replaced with tDb to represent tolerogenic DC behavior
in the blood.
T-cells in the Bloodstream




Q sple e n
Q panc
d
Eb 
µSB (Ds )E s +
µPB E panc − (µ BP + µ BSE )E b (4.9)
dt
Q blood
Q blood
Q sple e n
Q panc
d
Rb 
µSB (tDs )R s +
µPB R panc −(µ BP + µ BSE )R b (4.10)
dt
Q blood
Q blood









Q sple e n
Q panc
d
Em b 
µSB (Ds )Em s +
µPB Em panc − (µ BP + µ BSE )Em b
dt
Q blood
Q blood
(4.11)
The above equations are for the effector T-cells, regulatory T-cells, and
memory T-cells in the blood, respectively. Recall that µSB (Ds ) represents
the
 gating
 term mentioned previously. We also have the conversion rate



Q sple e n
Q blood







in order to properly measure concentration, since the blood has a

different volume than the spleen. µPB represents the emigration

 rate from
the pancreas to the blood. We have the conversion rate

Q panc
Q blood

to account

for the difference in volume for the pancreas and the blood. For the last
term, we have that the T-cells are flowing out of the blood stream and into
the pancreas and spleen compartment at a rate of µ BP and µ BSE respectively.
Macrophages in the Bloodstream
Q panc
d
M b  −Jne w +
c ne w M
dt
Q blood





(4.12)

This equation is a new addition to the multi-compartment model, since the
fundamental multi-compartment model did not include macrophages. We
assume that the macrophages start in the bloodstream and enter the tissue
(pancreas) at a constant rate Jne w . Jne w is related to J, the original macrophage
influx rate in
 the single-compartment model, through the following equation:
Jne w

Q blood
Q panc

 J. Something to note here is that J in the single-compartment

model has the value of 5 · 104 cells ml−1 d−1 , which was taken from Maree
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et al. (2006). However, this is a rounded value, and Maree et al. (2006) cites
the more correct estimation to be approximately 4.8 · 104 cells ml−1 d−1 . Thus,
we use this closer approximation for our J value.
We also assume that macrophages leave the pancreas and enter the
bloodstream at a rate of c ne w . This parameter is the same parameter c used
in the single-compartment model. However, we note that the value of c
can be ranged from 0.07 to 0.25, as stated in Maree et al. (2006). So, in the
multi-compartment model, c ne w  0.117.
Pancreas Compartment
β-cells in the Pancreas
Below is the equation for the healthy β-cell populations. This equation is
identical to the equation in the single-compartment model.
d
B  α B K1 (G)B − δ B B − W(B, t) − ηK 2 (E panc , R panc )B
dt
where
K1(G) 

(4.13)

G2
G 2 + G2hb

is the function relating the population of healthy β-cells to glucose.
K2(E panc , R panc ) 

(s E E panc )2
1 + (s E E panc )2 + (s R R panc )2

is the function that defines the interaction between T-cells and healthy β-cells.
W(B, t)  0.1Be −(

t−9 2
9 )

is the function representing the apoptotic wave.
Below is the equation for the apoptotic β-cells. This equation is also
identical to the equation presented in the single-compartment model.
d
B a  W̃(B, t) + η̃K2(E panc , R panc )B − f M MB a − f Ma M a B a
dt
− dB a + δ˜B B − f tD (Dss − Dpanc )B a − f D Dpanc B a (4.14)
Lastly, this equation represents the necrotic β-cells.
d
B n  dB a − f M MB n − f Ma M a B n − f tD (Dss − Dpanc )B n − f D Dpanc B n
dt
(4.15)
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The equations for the healthy, apoptotic, and necrotic β-cells in this multicompartment model are identical to those presented in the single-compartment
model, because we assume that β-cells stay and interact with other cells
solely in the pancreas.
DCs in the Pancreas
d
Dpanc  f tD B n (Dss − Dpanc − tDpanc ) + f tD B n tDpanc − µPB Dpanc (4.16)
dt
d
tDpanc  f tD B a (Dss − Dpanc − tDpanc ) − f tD B n tDpanc − µPB tDpanc . (4.17)
dt
The equations for immunogenic and tolerogenic DCs in the pancreas are
similar. For the immunogenic DCs, naive dendritic cells are converted into
immunogenic DCs at a rate of f tD when encountering a necrotic β-cell.
Likewise, when a naive dendritic cell encounters an apoptotic β-cell, it
transforms into a tolerogenic DC. Lastly, both immunogenic and tolerogenic
DCs emigrate out of the pancreas into the bloodstream at a rate of µPB .
T-cells in the Pancreas





Q blood
d
E panc 
µ BP E b − µPB E panc
dt
Q panc





Q blood
d
R panc 
µ BP R b − µPB R panc
dt
Q panc



(4.18)
(4.19)



Q blood
d
Em panc 
µ BP Em b − µPB Em panc
dt
Q panc

(4.20)

The three equations above all have the same structure. T-cells are coming
into the pancreas at a rate µ BP . Because the pancreas
 and the blood have
different volume sizes, we require a conversion term,

are leaving the pancreas to the blood at a rate of µPB .

Q blood
Q panc

. Lastly, T-cells

Macrophages in the Pancreas





Q blood
d
M
Jne w +(k+b)Ma−c ne w M− f M MBa− f M MB n −e1 M(M+Ma)
dt
Q panc
(4.21)
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This equation is almost identical to the equation for macrophages

 in the
single-compartment model. The only differences are the Jne w

Q blood
Q panc

term to

represent the influx of macrophages to the pancreas and the c ne w to denote
the macrophage egress rate to the blood. We note that since the macrophages
are flowing in from the blood compartment, we must convert the
 Jne w term
so that it uses the appropriate volume term. However, Jne w

Q blood
Q panc

 J,

where J is the parameter used in the original single-compartment model.
d
Ma  f M MBa + f M MB n − kMa − e2 Ma(M + Ma)
(4.22)
dt
This equation is exactly the same as the equation presented in the singlecompartment model for activated macrophages.
Glucose and Insulin
d
G  R 0 − (G0 + SI I)G
dt

(4.23)

d
G2
B − δI I
(4.24)
I  σI 2
dt
G + GI 2
We remark that the glucose and insulin equations in the multi-compartment
model are identical to the equations found in the single-compartment model.

4.4

Parameter Values

Many of the parameters shown in Table 2.2 for the single-compartment model
are used in the multi-compartment model. However, the multi-compartment
model also requires new parameters (such as migration rates from/to
compartments). Thus, all parameters used in the multi-compartment model
are listed in Table 4.1.
Parameter

Balb-c mice

NOD mice

Units

µB

74.56

74.56

day−1

Q blood

3

3

ml

Meaning
dendritic cell
emigration rate from
blood to spleen
volume of mouse blood
compartment

Parameter Values

aD

0.2310

0.2310

day−1

aI

0.2310

0.2310

day−1

µ BSE

0.0220

0.0220

day−1

µPB

0.51

0.51

day−1

µ BP

0.1

0.1

day−1

Jne w

3.2333 · 103

3.2333 · 103

cells ml−1 d−1

µ∗SB

0.012

0.012

day−1

normal
µSB

0.1120

0.1120

day−1

∆µ
c ne w
k

0.1
0.117
0.4

0.1
0.117
0.4

day−1
day−1
d−1

b

0.09

0.09

d−1

fM

2 · 0.0623 · 10−5

0.0623 · 10−5

ml cell−1 d−1

e1

10−8

10−8

cell−1 d−1

e2

10−8

10−8

cell−1 d−1

αB
δB

0.0334
1/60

0.0334
1/60

d−1
d−1

η

0.02

0.02

d−1

37

death rate of
immunogenic DCs in
the spleen
death rate of
tolerogenic DCs in the
spleen
T-cell emigration rate
from blood to spleen
emigration rate of DCs
and T-cells from the
pancreas to the blood
emigration rate of DCs
and T-cells from the
blood to the pancreas
normal resting
macrophage influx
CTL migration rate
from the spleen to
blood at equilibrium
normal CTL migration
rate from spleen to
blood
normal
− µ∗SB
µSB
macrophage egress rate
Ma deactivation rate
macrophage
recruitment rate by M a
basal phagocytosis rate
per M for Balb-c mice
anti-crowding term for
macrophages
anti-crowding term for
macrophages
β-cell growth rate
β-cell death rate
rate at which T-cells
eliminate β-cells
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mg

d−1

G hb

90

90

sE

1

1

ml cells−1

sR

36

36

ml cells−1

B conv

2.59 · 105

2.59 · 105

cell mg−1

Q panc

0.194

0.194

ml

d

0.50

0.50

d−1

f Ma

5 · 0.0623 · 10−5

0.0623 · 10−5

ml cells−1 d−1

f tD

1.1899 · 10−6

1.1899 · 10−6

ml cells−1 d−1

Dss

105

105

cells ml−1

fD

1.7101 · 10−7

1.7101 · 10−7

ml cells−1 d−1

R0

864

864

mg dl−1

G0

1.44

1.44

d−1

SI

0.72

0.72

ml µU−1 d−1

σI

43.2

43.2

µU ml−1 d−1 mg−1

GI

141.4214

141.4214

mg dl−1

δI

432

432

d−1

b DE

0.487 · 10−5

0.487 · 10−5

ml cells−1 d−1

µD

0.51

0.51

d−1

glucose level of
half-max β-cell
production
Relative impact of
effector T-cells on β-cell
death
Relative impact of
regulatory T-cells on
β-cell death
β-cells per milligram
volume of mouse
pancreas
β-cell death rate
activated phagocytosis
rate per Ma
rate naive DC engulf
apoptotic β-cells
steady-state DC
population
rate naive DC engulf
necrotic β-cells
basal rate glucose
production
rate of glucose decay
insulin rate of glucose
elimination
maximum rate of
insulin production by
β-cells
glucose level of
half-max insulin
production
rate of insulin decay
DC elimination rate by
effector T-cells
DC death rate

Parameter Values

b IR

0.487 · 10−5

0.487 · 10−5

ml cells−1 d−1

aE

0.1199

0.1199

d−1

Tnaive

370

370

cells

Q sple e n

0.1

0.1

ml

bp

12

12

d−1

θD

2.12 · 105

2.12 · 105

d−1

r am

0.01

0.01

d−1

bE

10−3

10−3

ml d cells−1

µE

2 · 10−6

2 · 10−6

d−1

aR

0.1199

0.1199

d−1

bR

10−3

10−3

ml d cells−1

µR

2 · 10−6

2 · 10−6

d−1

a Em

0.01

0.01

d−1
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DC elimination rate by
regulatory T-cells
rate of initial expansion
of naive T-cells to
effector T-cells
number of naive T-cells
contributing to initial
production of effector
and regulatory T-cells
volume of mouse
spleen
maximum expansion
rate of effector T-cells
due to DCs
DC value for
half-maximal effector
T-cell expansion
reversion rate of T-cells
to memory T-cells
activation rate for
effector T-cells from
memory T-cells
effector T-cell removal
rate due to competition
rate of initial expansion
of naive T-cells to
regulatory T-cells
activation rate for
regulatory T-cells from
Em T-cells
regulatory T-cell
removal rate due to
competition
memory T-cell death
rate
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Table 4.2 Here is the list of all parameters used in the multi-compartment
model. Parameters highlighted in blue are new parameters that are used exclusively in the multi-compartment model. Parameters highlighted in red (specifically, Jne w and c new ) are parameters that exist in the single-compartment model
but have different values. Parameters in black are parameters that have the
same value in both the single-compartment and the multi-compartment model.

4.5

Results

For the NOD mice, we were able to attain diverging behaviors for NOD mice
with the apoptotic wave and NOD mice without the wave. Specifically, we
saw that for NOD mice experiencing the wave, there was a spike in blood
glucose levels, leaving them in a diabetic state (of above 250 mg/dl).
For Balb-c mice, we see that regardless of the presence of a wave, the
Balb-c mice would stay healthy, which is what we observed in the single
compartment model. The results of the multi-compartment model can be
seen in Figure 4.3. A comparison between the single compartment and
multi-compartment model is shown in Figure 4.4.

Figure 4.3 The image on the left is the result of running the multicompartment model for Balb-c mice. The presence of the wave does not affect
the glucose levels of the Balb-c mice at equilibrium. However, the result on the
right shows that NOD mice will become diabetic if they experience an apoptotic
wave but will stay healthy otherwise.

In Figure 2.2, we plotted the glucose, insulin, and β-cell populations
for the single-compartment model. We were able to achieve similar results
for the glucose, insulin, and β-cells populations for the multi-compartment

Summary

Figure 4.4 We have the results for both the single and multi-compartment
models for Balb-c mice on the left. On the right is the result for both models for
NOD mice. We can see that the behavior is relatively similar.

model, which can be seen in Figure 4.5.
We were also able to plot the immune cell populations in Figure 4.6 and
the dendritic cell dynamics in Figure 4.7. We can compare these results to
the results acquired in the single-compartment models, which are Figures
2.3 and 2.4.

4.6

Summary

We were able to create a 23-equation multi-compartment model for Type 1
Diabetes in mice. The results achieved with this model are similar to those
achieved with the single-compartment model.
Specifically, we were able to take the equations for each variable in
the single compartment model and separate certain interactions into their
appropriate compartments. In other words, in the single-compartment
model, we assumed that all variables interacted with each other in one
compartment, but in the multi-compartment model, we moved some of
these interactions to different compartments. For example, in the multicompartment model, we assumed that the elimination of DCs by T-cells
occurred in the spleen and thus moved that part of the DC equation (such
as the b IR · tDs R s term in the tolerogenic DC equation) to the spleen
compartment.
While the results are similar, we still do see some minor differences
between the two models. For example, in the case of the Balb-c mice that do
not experience the apoptotic wave, we see a small spike in glucose levels,
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Figure 4.5 These plots show the behavior of the β -cell, glucose, and insulin
populations in four different scenarios.

Summary

Figure 4.6 Here are the population levels for each of the three immune cells
(effector, regulatory, and memory) over time. This graph is very similar to the
graph obtained with the single-compartment model.
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Figure 4.7 Here are the plots of the dendritic cells and β -cell populations.
This behavior also matches the behavior observed in the single-compartment
model.

Summary
but we do not see this spike in the single-compartment model. Further
investigation is needed to determine why this spike happens and whether
we can reduce or eliminate it. We also note that the behaviors of the immune
cells and the DCs in the multi-compartment slightly vary from those of the
single-compartment model.
The macrophages equations may also still need tweaking, since those
equations are brand new and were not a part of the original multi-compartment
model developed by Professors Lisette de Pillis and Blerta Shtylla. Otherwise, we may continue to work with this multi-compartment model and add
a treatment compartment as well.
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Chapter 5

Discussion
5.1

Conclusion

The single-compartment model for Type 1 Diabetes is a simple yet powerful
tool to learn more about diabetes and allow for realistic simulations. With
just a single-compartment, it is able to accurately capture data recorded
in Balb-c and NOD mice. Additionally, it was able to find a window of
opportunity for which treatment would be most effective. The reason behind
this window of opportunity may have to do with the ratio between regulatory
and effector T-cells. Lastly, we were able to add stochastic elements to the
model to more accurately represent real-world data, since not all NOD mice
behave in the same way. While we were able to achieve some variance, we
would still like to see a delayed spike in glucose levels.
The multi-compartment is able to achieve similar results to the singlecompartment. It could also be more biologically accurate, since it slightly
incorporates time delays. The multi-compartment model currently includes
three compartments: the blood, the spleen, and the pancreas. With the
development of this model, we hope to develop a treatment compartment
that will be able to more accurately capture how treatments interact with the
body biologically. Currently, in the single-compartment model, we simulate
treatments and injections by simply increasing both populations of dendritic
cells. With the multi-compartment model, we hope to more realistically
model how treatments are actually administered.
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5.2

Future Work

The main goal moving forward will be to develop a biologically-accurate
treatment compartment for the multi-compartment model. Additionally,
we would like to perform a dynamical systems analysis on this model to
analyze the stability of its fixed points.
Similar to our goals with the single-compartment model, we could try
to incorporate a delay in spiking of the glucose levels. Recall that, with the
real-world NOD mice data, we saw four different kinds of spiking: early,
delayed, fast, and slow. We could try to model the different kinds of spiking
in our multi-compartment model as well. We could also try to incorporate
actual time delays in our multi-compartment model.
Another future direction would be to use this model as a foundation
for modeling Type 1 Diabetes in humans. This would require research on
parameter values for humans and analyzing the differences in biological
dynamics between humans and mice with T1D.
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